Table 3.
Adverse events by sex (drug therapy)
| Male Patients Receiving Drug (n = 687) | Female Patients Receiving Drug (n = 405) | |
|---|---|---|
| Event | n (%)* | n (%)* |
| Hyper- or hypothyroidism | 12 (1.7) | 6 (1.5) |
| Major proarrhythmic event (VT, VF) | 8 (1.2) | 2 (0.5) |
| Allergic reaction | 3 (0.4) | 4 (1.0) |
| Gastrointestinal abnormality excluding moderate/severe diarrhea | 3 (0.4) | 7 (1.7) |
| Hypotension | 2 (0.3) | 1 (0.2) |
| Liver injury/failure | 1 (0.1) | 2 (0.5) |
| Atrial proarrhythmic event | 1 (0.1) | - |
| Pulmonary toxicity | 1 (0.1) | - |
| Blindness | - | - |
| Heart failure | - | - |
| Kidney damage | - | - |
| Moderate or severe diarrhea | - | - |
| Renal failure | - | - |
| Severe headache | - | - |
| Torsades des pointes | - | - |
*
n (%) = number (percent) of patients who reported drug-related adverse event. Percent is calculated among patients who have received drug.